Junevity

Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multiple therapeutic programs towards a new era of medicines.

Company Details

Founded: 2023
Employees: Between 1 - 10 employees
Raised: $10,000,000
Public: No
Acquired: No
CEO: Janine Sengstack
Founders: Janine Sengstack

Company Collections

These are collections Junevity is a part of. Click on the collection name to view similar companies.

Junevity's Industries

Medical Organizations

Biotechnology Companies